Atria Investments LLC Veru Inc. Transaction History

Atria Investments LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 04, 2025	BUY	$0.49 - $0.7 $14,222 - $20,317	29,025 Added 11.46%	282,281 $163,000
Q1 2025 May 06, 2025	BUY	$0.45 - $1.28 $36,697 - $104,382	81,549 Added 47.49%	253,256 $124,000
Q4 2024 Feb 06, 2025	BUY	$0.58 - $0.93 $17,424 - $27,939	30,043 Added 21.21%	171,707 $111,000
Q3 2024 Nov 01, 2024	SELL	$0.77 - $1.04 $3,873 - $5,232	-5,031 Reduced 3.43%	141,664 $109,000
Q2 2024 Aug 13, 2024	BUY	$0.76 - $1.79 $111,488 - $262,584	146,695 New	146,695 $123,000

32.7K

Ticker VERU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,146,704
Market Cap $204M
Description
Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....

Get notified when there are updates to the investment portfolio of Atria Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Atria Investments LLC with notifications on news.